Stay updated with breaking news from Carol Addy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Business owners on Georgetown's Front Street want better parking options. A proposal to add paid parking has generated debate but there's no consensus solution.
Lille ; Cambridge ; Zurich ; May 9, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced that it is... | May 9, 2023
Share: Genfit SA (NASDAQ: GNFT) shares shot up 150% in the after-hours trading today. What Happened: The France-based late-stage biopharmaceutical company said in the after-hours Tuesday that positive results from the Phase 2 trial evaluating elafibranor in patients with Primary Biliary Cholangitis have been published. “These data support the potential for elafibranor as novel treatment in PBC and confirm the rationale of evaluating our compound in this disease in a pivotal Phase 3 trial,” said Carol Addy, the chief medical officer at Genfit. Why It Matters: Elafibranor was given the...